Sorafenib Tablet, Film Coated
Product Images NDC 24979-715

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 24979-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label 120s)

Sorafenib Tablets USP 200 mg film-coated tablets packaging label by Upsher-Smith Laboratories, LLC. The label includes a barcode, storage instructions, dosage information, and manufacturer details. The package is for oral use and contains 120 tablets.*

FDA Label Image

Fig 1 (Fig1)

This is a Kaplan-Meier survival probability graph comparing sorafenib and placebo treatment groups over 18 months from randomization. The chart shows survival probability percentages on the y-axis and months on the x-axis, with curves indicating higher survival for sorafenib (median 10.7 months) versus placebo (median 7.9 months). It includes hazard ratio (HR 0.69) and p-value (0.00058) statistics, along with numbers of patients at risk at various time points for both groups.*

FDA Label Image

Fig 3 (Fig3)

A Kaplan-Meier survival curve chart illustrating the proportion of progression-free survival over time in months for two groups: Sorafenib (N=207) and Placebo (N=210). The y-axis represents the proportion of progression-free survival, and the x-axis shows duration in months, with data points extending up to 30 months. The chart includes patient numbers at risk for each group at various time points.*

FDA Label Image

Image Description (Label 60s)

Label for Sorafenib Tablets, USP 200 mg film-coated tablets. The package contains 60 tablets and is labeled by Upsher-Smith Laboratories, LLC. The label includes a barcode, storage instructions, and manufacturer information for YaBAO Pharmaceutical Co., Ltd., Beijing, China. The product NDC is 24979-715-04.*

FDA Label Image

Image Description (Logo1)

FDA Label Image

Structural Formula (Structure)

Chemical structure of sorafenib, a pharmaceutical compound depicted with its molecular components, including aromatic rings, amide groups, and halogen substituents. The structure shows the arrangement of atoms that form the active ingredient sorafenib in the 200 mg film-coated tablet from Upsher-Smith Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.